163 filings
Page 6 of 9
6-K
p1rh88ojei9xvnxtk
6 Mar 18
Current report (foreign)
12:00am
6-K
d83wnqk4kg51cgt
23 Feb 18
ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants
12:00am
6-K
utu5 u5azh9xu98cnp
13 Feb 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
j7mq2vzmdqn 7y
26 Jan 18
ESSA to Present at Noble Capital Markets' NobleCon14
12:00am
6-K
kgxz9iq6j
26 Jan 18
ESSA Announces Management Team Change
12:00am
6-K
oa1b4y6mvf
17 Jan 18
ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule
12:00am
6-K
jxjscvxdx ob614gv
16 Jan 18
ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5 Million
12:00am
6-K
p7xowqubqrv793
9 Jan 18
ESSA Completes US$21 Million Equity Offering
12:00am
6-K
8i8l53hyhtl2g1
8 Jan 18
ESSA Announces Filing of Second Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering
12:00am
6-K
29ef47uxtd asz
3 Jan 18
ESSA Announces Filing of Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering
12:00am
6-K
c8su76p
22 Dec 17
Current report (foreign)
12:00am
6-K
iqunnp fmg7imfar
18 Dec 17
ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering
12:00am
6-K
odtl yjluig
13 Dec 17
ESSA Pharma Announces Overnight Marketed Equity Offering
12:00am
6-K
giczmgpm6 vux8q
13 Dec 17
ESSA Pharma Announces Pricing of Previously Announced Equity Offering
12:00am
6-K
l9vdv3f2a85oe
12 Dec 17
Current report (foreign)
12:00am
6-K
yplrdsa5x5ay01y43
22 Nov 17
ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX
12:00am
6-K
32rg q5elx7
11 Sep 17
ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans
12:00am
6-K
vlectj1d54z2
7 Sep 17
ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress
12:00am
6-K
lwe60ttw
1 Sep 17
ESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference
12:00am
6-K
wg7 7njtera0742c1
15 Aug 17
Condensed Consolidated Interim Financial Statements
12:00am